Recent Finacing
Recent Raise
Centrexion Therapeutics develops non-opioid chronic pain therapies and in-licenses mid-stage drugs; pipeline includes a TRPV1 knee osteoarthritis candidate in Phase 3 and CCR2, CB2, and SSTR4 programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Centrexion Therapeutics.
